Concepedia

Author

Benjamin Lyons

Memorial Sloan Kettering Cancer Center

Also Known As

B. Lyons, Benjamin Lyons

10

Publications

1.2K

Citations

9

H-Index

16

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterJohnson & Johnson (United States)Pinnacle Oncology Hematology
BL

About

Benjamin Lyons is an author at Memorial Sloan Kettering Cancer Center specializing in mood disorders, clinical psychiatry, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

115

2

Psychiatry

2

2

115

3

Health Sciences

1

1

102

4

Nursing

1

1

102

5

Dementia

1

1

102

Benjamin Lyons

×

9

Publications

1.2K

Citations

9

H-Index

YearCitations

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

F. Stephen Hodi, Marcus Ballinger, Benjamin Lyons,

Journal of Clinical Oncology

2018

361

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

Michael S. Gordon, Daniela Matei, Carol Aghajanian,

Journal of Clinical Oncology

2006

249

Risperidone in the treatment of acute mania

Sumant Khanna, Eduard Vieta, Benjamin Lyons,

The British Journal of Psychiatry

2005

188

Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy

David B. Agus, Christopher J. Sweeney, Michael J. Morris,

Journal of Clinical Oncology

2007

103

Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone

Peter Paul De Deyn, Ira R. Katz, Henry Brodaty,

Clinical Neurology and Neurosurgery

2005

102

Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer

Roy S. Herbst, Angela M. Davies, Ronald B. Natale,

Clinical Cancer Research

2007

98

A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma

Howard Sofen, Kenneth G. Gross, Leonard H. Goldberg,

Journal of the American Academy of Dermatology

2015

78

Behavioural and Psychological Symptoms of Alzheimer Type Dementia Are Not Correlated with Plasma Homocysteine Concentration

Naji Tabet, H. Rafi, Gary Weaving,

Dementia and Geriatric Cognitive Disorders

2006

20

P.2.080 Risperidone in the treatment of acute bipolar mania: A double-blind, placebo-controlled study of 290 patients

S. Khanna, Eduard Vieta, Benjamin Lyons,

European Neuropsychopharmacology

2003

13

Page 1